Vitalise-Project / VITALISE & PRISMAP: Opening up Research Infrastructures to the European Community

VITALISE & PRISMAP: Opening up Research Infrastructures to the European Community

VITALISE and PRISMAP Project joined forces today to discuss about common interests and synergetic opportunities to facilitate access to Research Infrastructures for the whole European research community and beyond.

The VITALISE Project Coordinator, Dr Evdokimos Konstantinidis, Despoina Petsani (Harmonisation Board Coordinator) and Ada Pellumbaj (Dissemination and Communication Manager) met with members of the Project Management and Coordinator team of PRISMAP project, Prof. Thomas Elias Cocolios  and Iris Dimbwadyo on Monday, 28 February 2022 to discuss about common interests, potential collaborations and exchange knowledge about how to facilitate access to research infrastructures for the research community in Europe and beyond.

The main agenda items were:

  • The presentation of the two projects’ scope and objectives.
  • Open discussion on the optimisation of the process of providing access to European researchers in research infrastructures in Europe.
  • The exploration of opportunities to collaborate and promote the interests, goals and common good of both projects.
  • The establishment of synergies to work collaboratively on the communication and dissemination of the outputs and outcomes of the two projects.
  • The organisation of joint events along with other INFRAIA EU-funded projects to make European research infrastructures sustainable and open to the whole research community.

The discussion was very fruitful in terms of discussions, with interesting outcomes and essential exchange of knowledge.


PRISMAP is the European medical radionuclide programme on the production of high purity radionuclides (radioactive isotopes) by mass separation. We federate a European consortium of the key intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical and healthcare research institutes in the active translation of the emerging radionuclides into medical diagnosis and treatment.

PRISMAP will create a single-entry point for a fragmented user community distributed amongst universities, research centres, industry and hospitals, in a similar way as how the National Isotope Development Center (NIDC), supported by the Department of Energy (DOE), has provided radionuclide sources for users in the USA. PRISMAP brings together a consortium of 23 beneficiaries from 13 countries, one European Research Laboratory and an International Organisation. It receives support of leading associations and institutions in the field such as the European Association of Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA).